ImmuCell CorporationICCCNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+7.4%
5Y CAGR+11.7%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+7.4%/yr
vs +9.3%/yr prior
5Y CAGR
+11.7%/yr
Recent deceleration
Acceleration
-1.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$6.75M+18.8%
2024$5.68M+8.8%
2023$5.22M-4.2%
2022$5.45M+28.9%
2021$4.23M+8.8%
2020$3.89M-2.9%
2019$4.01M+4.8%
2018$3.82M+11.9%
2017$3.42M+4.0%
2016$3.29M-